1-15 of 55
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
CME/CENovel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
CME/CESjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast ReplayEmerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
CME/CE Broadcast ReplayEnhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
Deepak Sambhara, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEOvercoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEPatient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
- advertisement
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEIt Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CEAddressing Unmet Needs in Metastatic Uveal Melanoma
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
Justis P. Ehlers, MD, FASRS
Roger A. Goldberg, MD, MBA
Jennifer, I. Lim, MD, FASRS, FARVO
Ehsan Rahimy, MD
Second-Generation Biomarkers for Treatment Outcomes
MinuteCE®Second-Generation Biomarkers for Treatment Outcomes
Justis P. Ehlers, MD, FASRS
Jennifer, I. Lim, MD, FASRS, FARVO
Beyond Durability - What Biomarkers Reveal About Disease Control
MinuteCE®Beyond Durability - What Biomarkers Reveal About Disease Control
Justis P. Ehlers, MD, FASRS
Jennifer, I. Lim, MD, FASRS, FARVO
- advertisement
Macular Leakage: Indicator of Vascular Stability
MinuteCE®Macular Leakage: Indicator of Vascular Stability
Justis P. Ehlers, MD, FASRS
Jennifer, I. Lim, MD, FASRS, FARVO
Signs of Progress: PED as a Predictor of Disease and Outcomes
MinuteCE®Signs of Progress: PED as a Predictor of Disease and Outcomes
Justis P. Ehlers, MD, FASRS
Jennifer, I. Lim, MD, FASRS, FARVO
Fluid Foundations: How Location Impacts Outcomes in nAMD
MinuteCE®Fluid Foundations: How Location Impacts Outcomes in nAMD
Roger A. Goldberg, MD, MBA
Ehsan Rahimy, MD
